Stemline Therapeutics, Inc. EBITDA 2013-2020 | STML
Stemline Therapeutics, Inc. ebitda from 2013 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Stemline Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-80 |
| 2018 | $-86 |
| 2017 | $-68 |
| 2016 | $-39 |
| 2015 | $-37 |
| 2014 | $-29 |
| 2013 | $-24 |
| 2012 | $-6 |
| 2011 | $-3 |
| 2010 | $-2 |
| 2009 | $-2 |
| Stemline Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-03-31 | $-22 |
| 2019-12-31 | $-19 |
| 2019-09-30 | $-16 |
| 2019-06-30 | $-18 |
| 2019-03-31 | $-28 |
| 2018-12-31 | $-27 |
| 2018-09-30 | $-21 |
| 2018-06-30 | $-19 |
| 2018-03-31 | $-19 |
| 2017-12-31 | $-22 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-16 |
| 2017-03-31 | $-15 |
| 2016-12-31 | $-10 |
| 2016-09-30 | $-10 |
| 2016-06-30 | $-9 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-10 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-10 |
| 2015-03-31 | $-8 |
| 2014-12-31 | $-7 |
| 2014-09-30 | $-7 |
| 2014-06-30 | $-6 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-5 |
| 2013-03-31 | $-5 |
| 2012-12-31 | $-1 |
| 2012-09-30 | $-2 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-1 |
